Amanote Research

Amanote Research

    RegisterSign In

Priorities for CMV Vaccine Development

Vaccine - Netherlands
doi 10.1016/j.vaccine.2013.09.042
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
Date

December 1, 2013

Authors
Philip R. KrauseStephanie R. BialekSuresh B. BoppanaPaul D. GriffithsCatherine A. LaughlinPer LjungmanEdward S. MocarskiRobert F. PassJennifer S. ReadMark R. SchleissStanley A. Plotkin
Publisher

Elsevier BV


Related search

Vaccine Development for Syphilis

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

Background for Strategic Priorities for Development of Regional Universities

2018English

Viral Vectors for Vaccine Development

2013English

Macro Level Priorities for Livestock Research and Development for Bihar

Agricultural Economics Research Review
2015English

Strategic Priorities for the Sustainable Development of Recreational Areas

Investytsiyi: praktyka ta dosvid
2018English

Theory for Prophylactic AIDS Vaccine Development

Uirusu. Journal of virology
Medicine
2009English

Lessons Learned From HIV-1 Vaccine Trials: New Priorities and Directions

Nature Immunology
AllergyImmunology
2013English

Development of an EliSPOT Assay for Detection of CMV-specific Immune Response

Microbiologia Medica
2010English

Architectural-Typological Priorities for Sustainable Development of the Urban Environment

URBAN CONSTRUCTION AND ARCHITECTURE
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy